Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)

The Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) is a multicenter, randomized, single blind, two-arm, placebo controlled Phase III trial with blinded outcome assessments to establish the safety and efficacy of single dose of convalescent plasma for preventing the progression from mild to severe COVID-19 illness.

• Type: Clinical Trial
• Archiver: The database of Genotypes and Phenotypes (dbGaP)